SCHEMBL29033319

SCHEMBL29033319

O=C(Nc1cccc(C2COCCN2)c1N1CCCCC1)c1ccc(-c2cn[nH]c2)o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ TSHR P16473 2/20 0.40
▸ ATM Q13315 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.40
▸ IRAK4 Q9NWZ3 2/20 0.39
▸ AKT1 P31749 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ MAPK8 P45983 3/20 0.37
▸ MAPK10 P53779 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28378703 0.83 TSHR (0.59) HPGDSMN1; SMN2GAATSHRATM
SCHEMBL28378686 0.82 CHEK1 (0.55) IRAK4
SCHEMBL29033220 0.82 HPGD (0.52) HPGDSMN1; SMN2GAALMNAMAPT
SCHEMBL28384221 0.81 HPGD (0.51) HPGDSMN1; SMN2GAALMNAMAPT
SCHEMBL28887694 0.78 HPGD (0.50) HPGDSMN1; SMN2GAALMNAMAPT
SCHEMBL28378617 0.76 PIM1 (0.41) KDM4ETSHRATMPOLBNPSR1
SCHEMBL28382394 0.76 MAPK10 (0.46) HPGDSMN1; SMN2KDM4ETSHRATM
SCHEMBL20598344 0.72 CSF1R (0.55) HPGDSMN1; SMN2GAALMNAMAPT
SCHEMBL20598310 0.72 CSF1R (0.55) HPGDSMN1; SMN2GAALMNAMAPT
SCHEMBL20598458 0.71 IRAK4 (0.50) HPGDSMN1; SMN2GAALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032642-B Kinase inhibitors and methods of making and using the same 里格尔药品股份有限公司 2023-07-18 — — CN claimed
CN-111032642-B Kinase inhibitors and methods of making and using the same 里格尔药品股份有限公司 2023-07-18 — — CN disclosed
Send feedback